Pre-Clinical Investigation of Anti-TFPI-Mediated Rebalancing Mechanisms in Non-Hemophilic Bleeding Disorders
Pre-Clinical Investigation of Anti-TFPI-Mediated Rebalancing Mechanisms in Non-Hemophilic Bleeding Disorders Convoca: Pfizer, Inc Termini: 01/07/2026
